Vimarsana
Biggest News Aggregation in the World

Modified Mayo Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Modified Mayo Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Modified Mayo Score Today - Breaking & Trending Today

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at In - Vimarsana News

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at In

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroenterology (GI) business,...

Harnessing small molecules to treat chronic inflammatory diseases - Vimarsana News

Harnessing small molecules to treat chronic inflammatory diseases

Learn how Abivax's small molecule treatment could benefit UC patients and why these drugs hold promise to treat autoimmune diseases.

Abivax reports 2023 financial results and operational - Vimarsana News

Abivax reports 2023 financial results and operational

Abivax reports 2023 financial results and operational update Raised EUR 500M in 2023, including a EUR 130M capital increase, two structured debt...

Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD - Vimarsana News

Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD

Patients with ulcerative colitis and Crohn's also experienced improved clinical remission

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months - Vimarsana News

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months

EQS-News: ABIVAX / Key word: Miscellaneous Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months 22.01.2024 / 08:30 CET/CEST The...